Welcome to our dedicated page for RadNet news (Ticker: $RDNT), a resource for investors and traders seeking the latest updates and insights on RadNet stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RadNet's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RadNet's position in the market.
Rhea-AI Summary
RadNet, Inc. (NASDAQ: RDNT) introduces MammogramNow, a screening mammography service debuting at Walmart Supercenter in Milford, Delaware. The innovative initiative aims to enhance breast health awareness and accessibility, integrating DeepHealth® technology into the Walmart Supercenter environment to provide convenient access to crucial breast cancer screening services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.51%
Tags
-
Rhea-AI Summary
RadNet, Inc. (RDNT) launches DeepHealth, a health informatics portfolio with a cloud-native operating system (OS) powered by clinical AI, aiming to revolutionize radiology's role in healthcare. The portfolio integrates data across enterprises and offers personalized workflow applications for clinical and operational professionals, with the potential to improve clinical outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
-
Rhea-AI Summary
RadNet, Inc. (NASDAQ: RDNT) to present at BofA Securities 2023 Leveraged Finance Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
Rhea-AI Summary
Maverick Medical AI (Maverick) (NASDAQ: RDNT) partners with RadNet, Inc. to integrate its autonomous AI-powered medical coding platform, achieving an 85 percent direct-to-bill rate. The partnership aims to optimize revenue cycle management, reduce operational costs, and increase reimbursement. Maverick's platform combines generative AI with medical coding domain knowledge, autonomously analyzing clinical notes and reports to generate reimbursement codes in real-time. The platform's auditing features enable real-time feedback collection, resulting in a significant boost in productivity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
RadNet, Inc. (NASDAQ: RDNT) to Present at Sidoti & Company Fall 2023 Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.37%
Tags
-
Rhea-AI Summary
RadNet, Inc. (NASDAQ: RDNT) reported a 14.8% increase in consolidated revenue to $402.0 million in Q3 2023. The Imaging Centers segment saw a 14.3% revenue increase to $399.1 million. Adjusted EBITDA from the Imaging Centers segment rose by 20.3% to $60.4 million. Adjusted earnings for Q3 2023 were $9.9 million, with aggregate procedural volumes up by 8.6%. AI revenue surged by 220.8% and a new joint venture was created with Cedars-Sinai in Los Angeles. RadNet revised its full-year 2023 guidance, increasing the Adjusted EBITDA range.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.61%
Tags
Rhea-AI Summary
RadNet to host conference call to discuss Q3 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.93%
Tags
-
Rhea-AI Summary
RadNet, Inc. (NASDAQ: RDNT) CFO to present at Sidoti & Company Fall 2023 Conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
-
Rhea-AI Summary
RadNet, Inc. (RDNT) reported a 13.9% increase in revenue to a quarterly record of $403.7 million in the second quarter of 2023, excluding revenue from the AI segment. Adjusted EBITDA from the Imaging Centers segment also saw a 14.7% increase to $63.7 million. The company raised $246 million in net proceeds from a public offering of common stock and had a $357 million cash balance as of June 30, 2023. RadNet has increased its full-year 2023 guidance levels for Revenue and Adjusted EBITDA from the Imaging Center Segment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.04%
Tags
Rhea-AI Summary
RadNet, Inc. (NASDAQ: RDNT) announced the addition of two executives to lead advancements in the company’s technology solutions, including radiology informatics and clinical and generative Artificial Intelligence (AI). Sham Sokka, PhD., has been named Chief Operating and Technology Officer of Digital Health at RadNet. Sanjog Misra has joined as Chief Commercial Officer of Digital Health. RadNet is a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers. The expansion of its management team is indicative of strong momentum in RadNet’s business and a commitment to its health informatics roadmap.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.88%
Tags
RadNet, Inc.
Nasdaq:RDNT
RDNT Rankings
RDNT Stock Data
3.78B
60.33M
11.46%
75.13%
4.02%
Dental Laboratories
Manufacturing
United States of America
LOS ANGELES
About RDNT
radnet, inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services in the united states based on the number of locations and annual imaging revenue. radnet has a network of 340+ owned and/or operated outpatient imaging centers. radnet's core markets include california, delaware, maryland, new jersey, and new york. together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, radnet has a total of approximately 7,300 employees.